Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.

Wien Klin Wochenschr. 2018.

Factor VII deficiency in major artery occlusion stroke.

Am J Hematol. 2018, 93(6):843-845.

Endolysosomal protease susceptibility of Amb a 1 as a determinant of allergenicity.

J Allergy Clin Immunol. 2018, 141(4):1488-1491.e5.

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.

Ann Hematol. 2018.

Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.

WIEN KLIN WOCHENSCHR. 2018, 130(19-20): 569-574.

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).

BMC Cancer. 2018, 18(1): 1074.

Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia.

Mol Cancer Res. 2018, 16(3):428-438.

Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia.

BLOOD ADV. 2018, 2(16): 2063-2071.

RNA Trans-Splicing Modulation via Antisense Molecule Interference.

Int J Mol Sci. 2018, 19(3).

Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.

Ann Surg. 2018.